Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$504M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$335M |
| 4 |
Bank of America
BAC
|
+$324M |
| 5 |
TSMC
TSM
|
+$297M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.62B |
| 2 |
Meta Platforms (Facebook)
META
|
+$471M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$396M |
| 4 |
NVIDIA
NVDA
|
+$391M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.25% |
| 2 | Technology | 2.31% |
| 3 | Consumer Discretionary | 1.61% |
| 4 | Financials | 1.35% |
| 5 | Healthcare | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
11576
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $57.2K | ﹤0.01% |
32,500
-127,900
| -80% | -$365K |
|
|
MBAI
11577
Check-Cap
MBAI
$9.04M
| $57.1K | ﹤0.01% |
+5,704
| New | +$120K |
|
11578
PUT
Vroom Inc
VRM
$47.7M
| $57K | ﹤0.01% |
791
-2,000
| -72% | -$162K |
|
|
BCOV
11579
CALL
DELISTED
Brightcove, Inc.
BCOV
| $57K | ﹤0.01% |
12,800
-11,500
| -47% | -$64.2K |
|
11580
CALL
Katapult Holdings
KPLT
$480M
| $56.8K | ﹤0.01% |
5,052
-9,176
| -64% | -$199K |
|
11581
PUT
Alpha Pro Tech
APT
$55.8M
| $56.6K | ﹤0.01% |
13,600
-217,200
| -94% | -$901K |
|
|
AKTS
11582
CALL
DELISTED
Akoustis Technologies Inc
AKTS
| $56.4K | ﹤0.01% |
+18,300
| New | +$63.9K |
|
11583
CALL
Acacia Research
ACTG
$438M
| $56.4K | ﹤0.01% |
14,600
+4,000
| +38% | +$16.9K |
|
11584
CALL
Douglas Elliman
DOUG
$169M
| $56.3K | ﹤0.01% |
19,005
+2,835
| +18% | +$11.3K |
|
|
CKPT
11585
PUT
DELISTED
Checkpoint Therapeutics
CKPT
| $56.3K | ﹤0.01% |
+25,000
| New | +$125K |
|
|
EXPR
11586
PUT
DELISTED
Express, Inc.
EXPR
| $56.2K | ﹤0.01% |
3,560
-6,645
| -65% | -$134K |
|
|
TVRD
11587
PUT
Tvardi Therapeutics
TVRD
$24M
| $56K | ﹤0.01% |
317
-339
| -52% | -$114K |
|
11588
CALL
OppFi
OPFI
$609M
| $56K | ﹤0.01% |
27,300
-25,600
| -48% | -$53.8K |
|
11589
ALX Oncology
ALXO
$283M
| $55.8K | ﹤0.01% |
+12,355
| New | +$93.6K |
|
11590
PUT
Smart Sand
SND
$214M
| $55.8K | ﹤0.01% |
31,700
-60,500
| -66% | -$113K |
|
|
BXRX
11591
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $55.8K | ﹤0.01% |
+32,812
| New | +$83.5K |
|
11592
Energy Services of America
ESOA
$218M
| $55.6K | ﹤0.01% |
24,283
+11,554
| +91% | +$28.3K |
|
11593
CALL
MiMedx Group
MDXG
$657M
| $55.6K | ﹤0.01% |
16,300
-4,900
| -23% | -$19K |
|
|
YARW
11594
Yarrow Bioscience
YARW
$101M
| $55.5K | ﹤0.01% |
360
+342
| +1,900% | +$61.4K |
|
|
NIU
11595
PUT
Niu Technologies
NIU
$154M
| $55.5K | ﹤0.01% |
13,400
-12,600
| -48% | -$58.4K |
|
11596
CALL
Nkarta
NKTX
$197M
| $55.4K | ﹤0.01% |
15,600
+3,100
| +25% | +$14.7K |
|
11597
CALL
American Resources Corp
AREC
$272M
| $55.4K | ﹤0.01% |
36,900
-148,000
| -80% | -$221K |
|
|
SPPI
11598
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $55.4K | ﹤0.01% |
73,800
+27,600
| +60% | +$20.1K |
|
|
IRD
11599
Opus Genetics
IRD
$320M
| $55.3K | ﹤0.01% |
14,751
-15,451
| -51% | -$55.5K |
|
|
AACG
11600
ATA Creativity
AACG
$41.1M
| $55.3K | ﹤0.01% |
+28,222
| New | +$48.5K |
|
Similar funds
Jeff Yass's Q1 2023 Portfolio in Review
As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q1 2023 filing shows 2,075 new, 5,756 increased, 4,471 reduced and 1,856 closed positions. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M. The largest sale was Tesla, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
- Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
- Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
- Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
- Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
- Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.